Overactive bladder drugs and constipation: a meta-analysis of randomized, placebo-controlled trials.
about
An update on the use of transdermal oxybutynin in the management of overactive bladder disorderHow to treat the frail elderly: The challenge of multimorbidity and polypharmacyDisorders of gastrointestinal hypomotilityCost-effectiveness analysis of newer anticholinergic drugs for urinary incontinence vs oxybutynin and no treatment using data on persistence from the Swedish prescribed drug registry.An overview of the clinical use of antimuscarinics in the treatment of overactive bladderComparative Evaluation of the Safety and Efficacy of Long-Term Use of Imidafenacin and Solifenacin in Patients with Overactive Bladder: A Prospective, Open, Randomized, Parallel-Group Trial (the LIST Study)A prospective, comparative study of the occurrence and severity of constipation with darifenacin and trospium in overactive bladder.A review and additional post-hoc analyses of the incidence and impact of constipation observed in darifenacin clinical trialsAre solifenacin and ramosetron really ideal to treat irritable bowel syndrome?Experience with imidafenacin in the management of overactive bladder disorderUpdate on the management of overactive bladder: patient considerations and adherenceRationale for the use of anticholinergic agents in overactive bladder with regard to central nervous system and cardiovascular system side effects.Female Functional Constipation Is Associated with Overactive Bladder Symptoms and Urinary Incontinence.Oxybutynin gel for the treatment of overactive bladder.Antimuscarinic treatment in overactive bladder: special considerations in elderly patients.Pharmacokinetics and toxicity of antimuscarinic drugs for overactive bladder treatment in females.Safety and tolerability of β3-adrenoceptor agonists in the treatment of overactive bladder syndrome - insight from transcriptosome and experimental studies.Comparative functional selectivity of imidafenacin and propiverine, antimuscarinic agents, for the urinary bladder over colon in conscious rats.Do Effects on Bowel Patterns Imposed by Solifenacin Always Have Negative Impacts on Treating Patients with Overactive Bladder (OAB)?Factors influencing patient satisfaction with antimuscarinic treatment of overactive bladder syndrome: results of a real-life clinical study.Effect of anticholinergics on the overactive bladder and bowel domain of the electronic personal assessment questionnaire (ePAQ).Differential effects of selective and non-selective muscarinic antagonists on gastrointestinal transit and bowel function in healthy women.Influence of antimuscarinic therapy on cognitive functions and quality of life in geriatric patients treated for overactive bladder.Neuromodulation for Overactive Bladder Symptoms in Women Utilizing Either Motor or Sensory/Motor Provocation With a Minimum Nine-Year Follow-Up.Management of constipation in patients with Parkinson's disease.
P2860
Q26749105-2E688743-4F75-4960-9C46-155B5601C736Q26822934-5F16D844-52B6-4913-B86A-56B2A1B2FC61Q28070278-9E09EB45-1685-4439-BDC9-23C481085A3BQ34077022-7A43760B-FCEE-4427-A5B2-1943B354AC00Q35042575-D499EFCA-07AE-4890-A340-52458F6A06FAQ35419834-7A557826-475B-4417-9217-0EDAF453A1BDQ35548496-82F047F6-BACB-4AAD-BD57-DA25E37DF55EQ36307893-256F1B31-E201-4EB9-BCD7-1DB756204B0DQ36341742-132B1428-54A5-464B-9D74-FB1B23047985Q36541100-7300D3E7-AAC6-4594-A017-FC7A537B9261Q37283704-9CDF178C-BF44-4BE6-8B33-8139D130B979Q37399563-347261A4-D854-43BC-9EE3-3162CF12DE08Q37699850-69C8EECF-3A6A-452B-B5A6-364AA47B078DQ38011202-3C0C9830-3009-4DDE-8CA0-C1C208FA910DQ38020185-0127278F-5EE5-4753-980B-B5C078E1C991Q38032608-81937024-E480-486B-B2F9-F9728AAAC806Q38765381-960B46FE-9B59-47FE-81FE-9BAC99426C23Q43336546-67F18C16-21BF-45E0-8917-00F85224698FQ43348281-EB628EDA-B0AE-439C-967D-6C7FD3808B14Q44874780-AA4B5B95-B22F-441E-A095-CDEC0E6F0CA0Q45187452-A7227220-9C62-4DC7-8075-89C8B41E1F29Q45997528-B3335FD2-6896-401C-94EB-6EFF6670144FQ48054495-C6CA4E1A-99DE-48DD-AFA1-4E63809E8C9AQ51278714-C96C5AE4-5312-4314-9A99-7A436015CED5Q55467298-DA79EFF9-0503-4953-86E8-5A0B61772512
P2860
Overactive bladder drugs and constipation: a meta-analysis of randomized, placebo-controlled trials.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Overactive bladder drugs and c ...... ed, placebo-controlled trials.
@ast
Overactive bladder drugs and c ...... ed, placebo-controlled trials.
@en
Overactive bladder drugs and c ...... ed, placebo-controlled trials.
@nl
type
label
Overactive bladder drugs and c ...... ed, placebo-controlled trials.
@ast
Overactive bladder drugs and c ...... ed, placebo-controlled trials.
@en
Overactive bladder drugs and c ...... ed, placebo-controlled trials.
@nl
prefLabel
Overactive bladder drugs and c ...... ed, placebo-controlled trials.
@ast
Overactive bladder drugs and c ...... ed, placebo-controlled trials.
@en
Overactive bladder drugs and c ...... ed, placebo-controlled trials.
@nl
P2093
P1476
Overactive bladder drugs and c ...... zed, placebo-controlled trials
@en
P2093
Bora Gumustop
Darren M Triller
Dianne Roux-Lirange
Patrick D Meek
Samuel D Evang
P2860
P2888
P356
10.1007/S10620-010-1313-3
P50
P577
2010-07-02T00:00:00Z
P6179
1029911664